Crossmark

Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study

Crossref DOI link: https://doi.org/10.1016/j.abd.2021.09.009

Published Print: 2022-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Grumach, Anete S. http://orcid.org/0000-0002-9803-0309
Henriques, Marina T. http://orcid.org/0000-0002-6028-9307
Bardou, Maine L.D. http://orcid.org/0000-0001-9831-4080
Pontarolli, Daniele A. http://orcid.org/0000-0002-6661-5337
Botha, Jaco

Correa, Mariangela http://orcid.org/0000-0003-4856-7578
License Information

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-04-26
More Information

This article is maintained by: Elsevier

Article Title: Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2021.09.009

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.

Document is current

Any future updates will be listed below